Apyx Medical Corp (BOV.SG)
- Business Wire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
CLEARWATER, Fla., April 25, 2024--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2024 will be released before the market opens on Thursday, May 9th.
- Business Wire
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
CLEARWATER, Fla., April 11, 2024--Apyx® Medical Corporation (NASDAQ:APYX) (the "Apyx Medical"; "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, is pleased to announce the Renuvion Users’ Summit is taking place in Las Vegas from April 12-13, 2024.
- Simply Wall St.
Downgrade: Here's How Analysts See Apyx Medical Corporation (NASDAQ:APYX) Performing In The Near Term
One thing we could say about the analysts on Apyx Medical Corporation ( NASDAQ:APYX ) - they aren't optimistic, having...
